Study of Low Level Laser Therapy and Word Recognition in Hearing Impaired Individuals

Sensorineural Hearing Loss Clinical Trial

Official title:

The Effects of the Erchonia Hearing Laser on Word Recognition in Hearing Impaired Individuals Clinical Study Protocol

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00787189
• Other study ID #: EHL-001
• Status: Completed
• Phase: N/A
• Start date: August 2007
• Est. completion date: June 2008

Study information

• Verified date: May 2021
• Source: Erchonia Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this clinical study is to determine the effectiveness of low level laser light therapy when applied around the head and ears in improving unaided word recognition in ears with sensorineural hearing loss.

Description:

Sensorineural hearing loss accounts for about 90% of all hearing loss and is found in 23% of individuals older than 65 years. Sensorineural hearing loss occurs when the hair cells of the inner ear and the neural pathways to the auditory cortex are damaged. In most cases, sensorineural hearing loss cannot be improved, reversed or 'cured.' Current treatment options focus on methods that amplify external sounds and on teaching the patient various strategies to 'retrain' the brain to interpret external stimuli. Low Level Laser Therapy was first applied for the treatment of inner ear diseases by Uwe Witt, MD of Hamburg, Germany in the 1980's. Hearing impaired patients have inflammation and/or atrophy of the tissues and neural pathways connected to and supporting the cochlea's cilia hair structure, the hearing mechanism of the inner ear. Low level laser therapy is believed to stimulate the mitochondria of the adipocyte cells, which subsequently increases the production of ATP. The resultant surge in ATP production works to repair damaged tissue and regenerate cells reversing some of the damage incurred to the cochlea and thus improving aspects of hearing function.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: June 2008
• Est. primary completion date: June 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Sensorineural hearing loss.
• Mild or greater degree.
• Adult onset.
• Gradual onset.
• Hearing loss stable over past 12 months.
• Etiology of presbyacusis or noise-induced hearing loss.
• Unaided word recognition score between 28% and 86%.
• English as primary spoken language.
• Willing and able to abstain from other treatments or medications to improve hearing ability.
• Willing and able to abstain from work or other activities that involve loud noise exposure.

Exclusion Criteria:

• Central auditory processing disorder.
• Active/recurrent middle ear infection.
• Meniere's disease.
• Tympanic membrane perforation/tubes.
• Cochlear implant.
• Removal of acoustic neuroma.
• Hyperacusis/misphonia.
• Photosensitivity disorder.
• Active infection/wound in head/ear region.
• Pregnant/lactating.
• Serious mental health illness.
• Significant developmental disability/cognitive impairment.
• History of drug/alcohol abuse.
• Involvement in litigation/worker's compensation/disability benefits for hearing loss.
• Other research participation in past 90 days.
• Use of ototoxic medications known to cause temporary or permanent hearing loss.

Related Conditions & MeSH terms

• Deafness
• Hearing Loss
• Hearing Loss, Sensorineural
• Sensorineural Hearing Loss

Intervention

Device:
• The Hearing Laser
Two 6-minute low level laser light applications to the head/neck/ears region, each one week apart.
• Placebo Laser
inactive low level laser light therapy with no therapeutic output

Locations

Country	Name	City	State
United States	McDonald Hearing Centers	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
Erchonia Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Participants Whose Change in Percent Correct Word Recognition Scores From Baseline to One Week After Study Treatment Equalled or Exceeded the Minimum Change in a Reference Chart.	Participants were asked to repeat 50 words presented one at a time through headphones to each ear separately at a comfortable listening level to the participant. The 50 words were from a phonetically-balanced list of monosyllabic words called the Central Institute for the Deaf (CID) W-22 lists. For each ear, each word repeated correctly was scored '1'. The total number correct for each ear was summed and multiplied by 2 to attain the percent of total words repeated correctly for each ear. The change in this percent from baseline to one week after study treatment was referenced against a chart. If the change was equal to or greater than the corresponding value in the chart, the participant was considered to have a successful study outcome.	baseline and one week